Could a simple MRI replace a PET scan for safer cancer radiation?
NCT ID NCT07609225
First seen May 27, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study will test whether a special MRI scan (CSE-MRI) can accurately measure active bone marrow in men with metastatic prostate cancer, compared to a standard PET scan using a radioactive tracer (FLT). Fifteen participants will receive both scans at the same time using a combined PET/MRI machine. If the MRI works as well as the PET scan, it could help doctors better protect bone marrow during radiation therapy, reducing side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-FLT (fluorothymidine) injection
What this could lead to
If successful, this could show that a simpler MRI scan can replace a PET scan for measuring active bone marrow, potentially making radiation therapy safer and more accessible.
What could go wrong
This is a very small, early-phase study with only 15 participants. It is testing imaging accuracy, not a treatment, so it will not directly improve health outcomes. The MRI method may not prove as reliable as PET.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.